By Josh White
Date: Tuesday 03 Mar 2026
(Sharecast News) - Shield Therapeutics said the Chinese National Medical Products Administration has accepted a marketing authorisation application for Accrufer, or ferric maltol, for the treatment of iron deficiency in adults.
| Acquisition of Shareholding in Deltic Energy Plc | 03-Mar-2026 | 18:20 | RNS |
| Form 8.3 - Essensys plc | 03-Mar-2026 | 18:01 | RNS |
| Holding(s) in Company | 03-Mar-2026 | 17:27 | RNS |
| Holding(s) in Company - Amendment | 03-Mar-2026 | 17:25 | RNS |
| Transaction in Own Shares and Total Voting Rights | 03-Mar-2026 | 17:23 | RNS |
| SkinBioTherapeutics dives after sudden exit of c... | 18-Feb-2026 | Times |
| Boohoo Group to tap shareholders for another £35... | 18-Feb-2026 | Times |
| EasyHotel CFO Darren Mee resigns | 26-Dec-2014 | Telegraph |
| Scotgold pays off RMB loan | 24-Dec-2014 | The Herald |
| Bowleven facing further delay | 24-Dec-2014 | The Herald |
| Questor :Optimal Payments | 18-Dec-2014 | Telegraph |
| Questor :Falkland Oil & Gas | 17-Dec-2014 | Telegraph |
| Questor :OPG Power Ventures | 10-Dec-2014 | Telegraph |
| Questor :Quindell | 10-Dec-2014 | Telegraph |
| Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
| Price | 786.43 |
| Change Today | -29.46 |
| % Change | -3.61 % |
| 02-Mar-26 Close | 815.89 |
You are here: research